|
| Status |
Public on Feb 09, 2021 |
| Title |
Integrative genomic analysis of gemcitabine resistance in pancreatic cancer by patient-derived xenograft models |
| Organism |
Homo sapiens |
| Experiment type |
Methylation profiling by genome tiling array
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
33674273 |
| Submission date |
Jan 29, 2021 |
| Last update date |
May 11, 2021 |
| Contact name |
Wenbo Guo |
| Organization name |
Tsinghua University
|
| Street address |
Haidian
|
| City |
Beijing |
| State/province |
Beijing |
| ZIP/Postal code |
100084 |
| Country |
China |
| |
|
| Platforms (2) |
| GPL13534 |
Illumina HumanMethylation450 BeadChip (HumanMethylation450_15017482) |
| GPL21145 |
Infinium MethylationEPIC |
|
| Samples (56)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE165687 |
DNA methylation data of PAC PDX models before Gemcitabine treatment |
| GSE165688 |
DNA methylation data of PAC PDX models after Gemcitabine treatment |
|
| Relations |
| BioProject |
PRJNA697853 |
Less...
More...